空心膠囊市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

2023 年全球空心膠囊市場價值為31 億美元，預計2024 年至2032 年複合年成長率為6.3%。保健品的需求不斷成長，很大程度上是由於人們健康意識的增強和健康意識的增強。此外，製藥業正在轉向膠囊製劑，因為膠囊製劑易於吞嚥，能夠掩蓋味道，並且具有控釋遞送的潛力，這使得它們成為比傳統片劑更受歡迎的選擇。

市場主要分為兩大類：明膠膠囊和非明膠膠囊。明膠細分市場佔據主導佔有率，預計到2032 年將以6.5% 的複合年成長率成長。保持產品穩定性。這些膠囊還具有卓越的生物利用度，確保活性成分更好地吸收。源自各種動物來源的明膠具有多功能性，使製造商能夠定製配方，使其適合各種消費者的喜好和需求。

在應用方面，市場分為不同的治療領域，包括維生素和膳食補充劑、抗生素、抗發炎藥物、心血管治療等。維生素和膳食補充劑細分市場是 2023 年的主要貢獻者，產生了可觀的收入。隨著注重健康的消費者擴大尋求方便有效的方法來增強營養攝入，對膠囊的需求激增。膠囊提供了一種理想的方法來傳遞這些補充劑，確保有效吸收和生物利用度。人口老化的不斷成長和預防性醫療保健的廣泛採用進一步推動了這一領域的需求。

美國在北美空心膠囊市場佔據關鍵地位，佔相當大的佔有率。該國的市場主導地位得到了強大的製藥和營養保健品行業的支持，同時消費者對膳食補充劑的需求不斷成長，以及個人化醫療的趨勢。美國也受益於尖端的製造技術和嚴格的監管標準，確保生產出符合消費者期望的高品質膠囊。此外，膠囊配方的創新以及素食和明膠選擇的日益普及也進一步促進了市場的擴張。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 對營養保健品和膳食補充劑的需求不斷增加
    • 製藥業的成長
    • 偏好膠囊劑型
  • 產業陷阱與挑戰
    • 品質控制和一致性
    • 生產成本高
• 成長潛力分析
• 監管環境
• 技術景觀
• 未來市場趨勢
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

• 主要趨勢
• 明膠
  • 豬明膠
  • 牛源性
  • 骨粉
  • 其他明膠膠囊類型
• 非明膠
  • 羥丙基甲基纖維素（HPMC）
  • 普魯蘭多醣和澱粉

第 6 章：市場估計與預測：按功能分類，2021 - 2032 年

• 主要趨勢
• 立即發布
• 持續釋放
• 延遲發布

第 7 章：市場估計與預測：按應用分類，2021 - 2032

• 主要趨勢
• 抗生素和抗菌藥物
• 維生素和膳食補充劑
• 制酸劑和抗脹氣製劑
• 抗貧血製劑
• 抗發炎藥
• 心血管治療藥物
• 咳嗽和感冒藥物
• 其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 製藥
• 營養保健品
• 其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 10 章：公司簡介

• ACG
• BioCaps Enterprise
• Bright Pharma Caps
• CapsCanada Corporation
• Chemcaps Limited
• Fortcaps Healthcare
• HealthCaps India
• Lonza Group
• Medi-Caps
• Nectar Lifesciences
• Qualicaps
• Shanxi JC Biological Technology
• Suheung
• Sunil Healthcare

The Global Empty Capsules Market, valued at USD 3.1 billion in 2023, is projected to grow at a CAGR of 6.3% from 2024 to 2032. This growth is driven by the rising demand for dietary supplements and nutraceuticals, largely fueled by greater health consciousness and the increasing preference for preventive healthcare. Furthermore, the pharmaceutical industry is shifting toward capsule formulations due to their ease of swallowing, ability to mask the taste, and potential for controlled-release delivery, which makes them a preferred choice over traditional tablets.

The market is primarily divided into two categories: gelatin and non-gelatin capsules. The gelatin segment holds a dominant share and is anticipated to grow at a CAGR of 6.5% through 2032. Gelatin capsules are widely used in both the pharmaceutical and dietary supplement industries, owing to their ability to protect sensitive ingredients from moisture and oxygen, thus maintaining product stability. These capsules also offer superior bioavailability, ensuring better absorption of active ingredients. The versatility of gelatin, derived from various animal sources, allows manufacturers to customize formulations, making them suitable for a wide range of consumer preferences and needs.

In terms of applications, the market is segmented into various therapeutic areas, including vitamins and dietary supplements, antibiotics, anti-inflammatory drugs, cardiovascular therapies, and others. The vitamins and dietary supplements segment was the leading contributor in 2023, generating significant revenue. As health-conscious consumers increasingly seek convenient and efficient ways to enhance their nutritional intake, the demand for capsules has surged. Capsules provide an ideal method for delivering these supplements, ensuring effective absorption and bioavailability. The growing aging population and the widespread adoption of preventive healthcare are further boosting the demand for this segment.

The U.S. holds a key position in the North American empty capsules market, accounting for a substantial share. The country's market dominance is supported by a strong pharmaceutical and nutraceutical sector, alongside increasing consumer demand for dietary supplements and the trend toward personalized medicine. The U.S. also benefits from cutting-edge manufacturing technologies and rigorous regulatory standards, which ensure the production of high-quality capsules that meet consumer expectations. Additionally, innovations in capsule formulations and the growing popularity of both vegetarian and gelatin options are further contributing to market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for nutraceuticals and dietary supplements
    • 3.2.1.2 Growth of pharmaceutical industry
    • 3.2.1.3 Preference for capsule-based dosage forms
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Quality control and consistency
    • 3.2.2.2 High production costs
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Gelatin
  • 5.2.1 Porcine gelatin
  • 5.2.2 Bovine derived
  • 5.2.3 Bone meal
  • 5.2.4 Other gelatin capsule types
• 5.3 Non-gelatin
  • 5.3.1 Hydroxypropyl methylcellulose (HPMC)
  • 5.3.2 Pullulan & starch

Chapter 6 Market Estimates and Forecast, By Functionality, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Immediate release
• 6.3 Sustained release
• 6.4 Delayed release

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Antibiotic and antibacterial drugs
• 7.3 Vitamins and dietary supplements
• 7.4 Antacid and anti-flatulent preparations
• 7.5 Anti-anemic preparations
• 7.6 Anti-inflammatory drugs
• 7.7 Cardiovascular therapy drugs
• 7.8 Cough and cold drugs
• 7.9 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Pharmaceutical
• 8.3 Nutraceutical
• 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 ACG
• 10.2 BioCaps Enterprise
• 10.3 Bright Pharma Caps
• 10.4 CapsCanada Corporation
• 10.5 Chemcaps Limited
• 10.6 Fortcaps Healthcare
• 10.7 HealthCaps India
• 10.8 Lonza Group
• 10.9 Medi-Caps
• 10.10 Nectar Lifesciences
• 10.11 Qualicaps
• 10.12 Shanxi JC Biological Technology
• 10.13 Suheung
• 10.14 Sunil Healthcare